
Telmisartan (40mg) + Nebivolol (5mg)
Active composition
+1 more active ingredient
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Nebivolol selectively blocks beta-1 adrenergic receptors, leading to vasodilation and reduced heart rate.
Medical applications
Nebilyst-T Tablet is a combined pharmaceutical agent containing Nebivolol 5mg and Telmisartan 40mg. This medication is primarily indicated for the management of essential hypertension (high blood pressure). Nebivolol, a beta-blocker, functions by decreasing the heart rate and force of heart contractions, thereby reducing blood pressure, while Telmisartan, an angiotensin II receptor antagonist, blocks the action of angiotensin II, a hormone that causes blood vessels to constrict, thereby increasing blood pressure. The combination of these two drugs aims to provide effective blood pressure control with potential added benefits such as reduced cardiovascular morbidity and mortality. As with any medication, Nebilyst-T Tablet should be used under the supervision of a healthcare provider, considering the individual's medical history and concomitant medications to minimize potential adverse effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nebilyst-T Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Nebilyst-T Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nebilyst-T Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Nebilyst-T Tablet may be needed. Please consult your doctor.
Exercise Caution
Nebilyst-T Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nebilyst-T Tablet should be used with caution in patients with liver disease. Dose adjustment of Nebilyst-T Tablet may be needed. Please consult your doctor. Use of Nebilyst-T Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Nebilyst-T Tablet

Nebivolol (5mg) + Telmisartan (40mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Nebivolol selectively blocks beta-1 adrenergic receptors, leading to vasodilation and reduced heart rate.
Medical applications
Nebilyst-T Tablet is a combined pharmaceutical agent containing Nebivolol 5mg and Telmisartan 40mg. This medication is primarily indicated for the management of essential hypertension (high blood pressure). Nebivolol, a beta-blocker, functions by decreasing the heart rate and force of heart contractions, thereby reducing blood pressure, while Telmisartan, an angiotensin II receptor antagonist, blocks the action of angiotensin II, a hormone that causes blood vessels to constrict, thereby increasing blood pressure. The combination of these two drugs aims to provide effective blood pressure control with potential added benefits such as reduced cardiovascular morbidity and mortality. As with any medication, Nebilyst-T Tablet should be used under the supervision of a healthcare provider, considering the individual's medical history and concomitant medications to minimize potential adverse effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nebilyst-T Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Nebilyst-T Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nebilyst-T Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Nebilyst-T Tablet may be needed. Please consult your doctor.
Exercise Caution
Nebilyst-T Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nebilyst-T Tablet should be used with caution in patients with liver disease. Dose adjustment of Nebilyst-T Tablet may be needed. Please consult your doctor. Use of Nebilyst-T Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Nebilyst-T Tablet















